2001
DOI: 10.1136/jech.55.2.126
|View full text |Cite
|
Sign up to set email alerts
|

Patient follow up screening evaluations. Examples with regard to congenital hip dislocation and congenital heart disease

Abstract: Objective-To discuss the merits of the patient follow up study design for the evaluation of some specific mass screening programmes. Design-Theoretical evaluation illustrated by two examples. Setting-Department of Public Health Erasmus University Rotterdam.Main results-The gold standard for evaluation of favourable eVects of screening is the randomised controlled trial (RCT). Application of an RCT, however, is often not feasible, in which cases observational studies will have to be relied on. The case-control … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

2002
2002
2008
2008

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 7 publications
0
4
0
Order By: Relevance
“…In cohort studies such as ours and that of Montgomery et al, the four types of bias, which can overestimate the effectiveness of screening, are lead-time bias, selection bias, length bias and over-treatment bias. 22 Lead-time bias occurs when patients do not reach the definite outcome during the study period. The screening population may contain a large proportion of patients with disorders in a very early stage who will not have reached the (adverse) outcome during the study period; this will lead to an overestimation of the positive effect of screening.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In cohort studies such as ours and that of Montgomery et al, the four types of bias, which can overestimate the effectiveness of screening, are lead-time bias, selection bias, length bias and over-treatment bias. 22 Lead-time bias occurs when patients do not reach the definite outcome during the study period. The screening population may contain a large proportion of patients with disorders in a very early stage who will not have reached the (adverse) outcome during the study period; this will lead to an overestimation of the positive effect of screening.…”
Section: Discussionmentioning
confidence: 99%
“…22 Lead-time bias occurs when patients do not reach the definite outcome during the study period. The screening population may contain a large proportion of patients with disorders in a very early stage who will not have reached the (adverse) outcome during the study period; this will lead to an overestimation of the positive effect of screening.…”
Section: Discussionmentioning
confidence: 99%
“…Actuarial survival is not an ideal measure for outcomes after screening, but lead time bias may be less likely to occur with studies of congenital anomalies as the condition is present from birth and the interval between birth and confirmed diagnosis may be short. 68 In addition, studies of survival after cardiac surgery varied in their reporting of actuarial survival, with some excluding early surgical mortality. We have selected figures only from reports which include early surgical mortality for this review.…”
Section: Methodological Considerations In Reporting Mortalitymentioning
confidence: 99%
“…12 However, overtreatment bias and length-biased sampling, leading to overestimation of the effect of screening, could be serious problems in such a study. 12,13 The present study investigated the effect of screening for scoliosis on reduction of the need for surgery. From a methodologic viewpoint, a RCT is the best design to establish the effectiveness of screening for scoliosis.…”
mentioning
confidence: 99%